The Netherlands Cancer Institute
The Netherlands Cancer Institute
Amsterdam, North Holland, Netherlands3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma | Neoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Retroperitoneal liposarcoma, liposarcoma, neoplasm, sarcoma | Recruiting | Not stated | 2026-07-15 | NCT07377747 | |
| Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations | Resectable MMR-deficient Solid Tumors; Resectable MMR-proficient Solid Tumors | Recruiting | Phase 2 / Phase 3 | 2026-03-05 | NCT06279130 | |
| Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 4 | 2024-05-13 | NCT05525338 |